These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4097526)

  • 21. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin and glucose determinations after two and three years of use of a combination-type oral contraceptive.
    Spellacy WN; Bendel RP; Buhi WC; Birk SA
    Fertil Steril; 1969; 20(6):892-902. PubMed ID: 5361464
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of a sequential oral contraceptive on endometrial enzyme and carbohydrate histochemistry.
    Hester LL; Kellett WW; Spicer SS; Williamson HO; Pratt-Thomas HR
    Am J Obstet Gynecol; 1968 Nov; 102(6):771-83. PubMed ID: 4176774
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences in ambulatory treatment of female diabetics with oral contraceptive agent, Ovosiston].
    Steindel E; Mohnike A; Langreck G
    Z Arztl Fortbild (Jena); 1971 Feb; 65(3):159-61. PubMed ID: 4102493
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of estrogen-gestagen combinations on carbohydrate and lipid-metabolism. 3. Effect of quinestrol-chlormadinone-acetate].
    Göretzlehner G; Herre HD; Töwe J
    Zentralbl Gynakol; 1973 Dec; 95(52):1831-7. PubMed ID: 4131833
    [No Abstract]   [Full Text] [Related]  

  • 26. Endometrial morphology after sequential medication with mestranol and chlormadinone.
    Ober WB; Decker A; Clyman MJ; Roland M
    Obstet Gynecol; 1966 Aug; 28(2):247-53. PubMed ID: 4161461
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the metabolic effects of chlormadinone acetate and conventional contraceptive steroids in man.
    Beck P
    J Clin Endocrinol Metab; 1970 Jun; 30(6):785-91. PubMed ID: 4192202
    [No Abstract]   [Full Text] [Related]  

  • 28. [Femigen forte and mite preparations in contraception and gynecologival disorders].
    Sternadel Z; Pietrusiewicz W; Wasilewska B
    Ginekol Pol; 1970 Nov; 41(11):1227-36. PubMed ID: 4098877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential administration of hormones for control of conception.
    Dougherty CM
    J La State Med Soc; 1966 Sep; 118(9):382-4. PubMed ID: 4166934
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of synthetic estroprogestational agents on the regulation of blood sugar and secretion of insulin].
    Caderas de Kerleau J; Durand G; Mirouze J; Orsetti A; Belaiche R
    Gynecol Obstet (Paris); 1971; 70(2):133-8. PubMed ID: 5563840
    [No Abstract]   [Full Text] [Related]  

  • 31. [Oral hormonal contraceptives and carbohydrate metabolism].
    Rubio-Lotvin B
    Ginecol Obstet Mex; 1996 May; 64():198-200. PubMed ID: 8925976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Gestranol used as a contraceptive on the level of some aminotransferases].
    Giermańska T; Jabloński K; Filc-Bauer A
    Pol Tyg Lek; 1972 Nov; 27(47):1839-40. PubMed ID: 4118898
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucose and insulin alterations after one year of combination-type oral contraceptive treatment.
    Spellacy WN; Carlson KL; Birk SA; Schade SL
    Metabolism; 1968 Jun; 17(6):496-501. PubMed ID: 4870715
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 38. Sequential estrogen and progestogen therapy. A clinical evaluation.
    Abrams AA
    Am J Obstet Gynecol; 1966 Dec; 96(7):1005-10. PubMed ID: 4162848
    [No Abstract]   [Full Text] [Related]  

  • 39. Cooperative studies of sequens, a sequential oral contraceptive agent, in Japan.
    Sawasaki C; Ashitaka Y
    J Jpn Obstet Gynecol Soc; 1968 Apr; 15(2):96-107. PubMed ID: 4175084
    [No Abstract]   [Full Text] [Related]  

  • 40. Electroencephalographic changes during long term treatment with oral contraceptives.
    Matsumoto S; Sato I; Ito T; Matsuoka A
    Int J Fertil; 1966; 11(2):195-204. PubMed ID: 4163250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.